Ketoprofen linked to higher GI risk than ibuprofen and naproxen -- meta-analysis.
This article was originally published in The Tan Sheet
Executive Summary
KETOPROFEN LINKED TO HIGHER RELATIVE RISK OF GI COMPLICATION in a meta-analysis of 12 NSAID studies conducted by David Henry, PhD, University of Newcastle, New South Wales, Australia, et al. that appears in a recent edition of the British Medical Journal. Ketoprofen ranked tenth among 12 NSAIDs examined for risk of serious gastrointestinal complications.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning